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I. INTRODUCTION
The Internet offers the potential to revolutionize the manner in which
people receive health information and treat their health conditions. More
than 40.9 million Americans were expected to use the Internet in the year
2000 for health care.1 "According to Investors Business Daily, 43 percent
of [W]eb surfers access health care data online each year. Health concerns
are the sixth most common reason that people use the Internet, and
according to the market research firm, Cyber Dialogue Inc., this number is
growing by 70 percent a year.
' 2
Even without the growth of the Internet, the twentieth century has
seen an incredible proliferation of health care services. Rather than simply
consulting a single family physician for all health-related matters, patients
now seek counsel from many individuals about needed services. The
Internet offers an easy, fast, and potentially more robust source of health
care .delivery. Noietheless, this incredible new medium also has the
potential to defraud consumers seeking health information and services in a
manner that probably would not have occurred had they simply consulted
their familiar-and trusted-licensed medical practitioners.
Generally, the health care industry has lagged behind other sectors in
the use of information technology services and solutions.3 In the modem
health care arena, however, sharing information is increasingly important
to facilitate patient diagnosis and treatment, insurance and benefit claim
evaluation and payment, public health monitoring, research, and health
care education and training. To respond to widespread consumer use of the
Internet for health-related reasons, health care organizations and services
1. Cyber Dialogue, Cyber Dialogue Releases Cybercitizen Health 2000 (Aug. 22,
2000), at http:/www.cyberdialogue.con/news/releases/2000/08-22-cch-launch.html.
2. Drugstores on the Net: The Benefits and Risks of Online Pharmacies, Hearings
Before the Subcomm on Oversight and Investigations of the House Comm. on Commerce,
106th Cong. 95-96 (1999) [hereinafter Hearings] (statement of Janet Woodcock, Director,
Center for Drug Evaluation and Research, Food and Drug Administration).
3. Cf. Douglas Gantenbein & Marcia Stepanek, Kaiser Takes the Cyber Cure, Bus.
WK., Feb. 7, 2000, at EB 80.
[Vol. 53
Number 2] PHARMACEUTICAL SALES ON THE INTERNET
must migrate from their traditional "bricks-and-mortar': establishments to
the Internet.5 Until two years ago, even Kaiser Permanente, the country's
largest health-maintenance organization ("HMO"), kept paper files for its
patients' and shipped records around the country by traditional truck
delivery. Today, Kaiser and many other HMOs and health care
professionals use the Internet to facilitate anything from individual account
access, communication between the patient and health care provider,
storage and transmission of patient data, to advice and discussion among
health professionals, drug and disease research, and product ordering
Before Internet health services overtake their bricks-and-mortar
counterparts, the law must ensure an adequate level of confidentiality and
control over consumers' personal health information; reliability of online
information; and direct redress for invasions of privacy and unfair,
deceptive, and fraudulent trade practices.
While online health care delivery raises many important issues, this
Comment offers a comparison of the American and Canadian legal
approaches to informational health privacy and Internet pharmacy sales.
The United States and Canada have taken different approaches to the
general protection of privacy, and this difference remains consistent
between the two nations' treatment of Internet medical privacy. While the
United States offers a patchwork of industry-specific privacy laws and
encourages industry self-regulation, Canada has recently enacted a
comprehensive privacy protection law that covers actions of both public
and private actors and gives consumers a private right of action.
Nonetheless, the United States has recently enacted a detailed medical
privacy law. While this industry-specific law covers actions of both public
and private actors, it does not give consumers a private right of action. This
U.S. law is likely more comprehensive in terms of medical privacy
protections because of its pinpoint focus, but it does not offer an industry-
neutral, umbrella privacy protection and individual redress that the
Canadian law promises. The advent of the Internet pharmacy, however, has
caught both countries off guard; thus, there likely will be more consistency
4. "Bricks-and-mortar" is a term traditionally used to describe a physical facility, as
opposed to a virtual establishment. "Click-and-mortar" is described as "[a] business that
combines traditional retail... and on-line e-commerce shopping." NEWTON, infra note 8, at
193.
5. The number of inviduals going online to retrieve health information "is growing
nearly twice as fast as thd4nternet population at large." ScoTr REGENTS, IMPAcTS OF THE
INTERNET ON THE DOCTOR-PATENT RELATIONSHIP: THE RISE OF THE INTERNET HEALTH
CONSUMER 1 (1999), available at http://www.cyberdialogue.com/pdfs/wp/wp-cch-1999-
doctors.pdf (last visited Jan. 24, 2001).
6. Gantenbein & Stepanek, supra note 3.
7. See id.
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and cross-country cooperation in the future regulations of Internet
pharmacy sales.
The Internet poses enhanced and unique concerns relative to
informational health privacy and pharmacy sales. As technology advances
and the Internet changes the way people obtain their medical services and
products, protecting health information and consumers in online
pharmaceutical transactions is paramount. Part II of this Comment explores
the existing legal frameworks in the United States and Canada relative to
informational health privacy and provides a comparative analysis of these
frameworks. Part III then examines, analyzes, and compares the existing
legal frameworks with regard to Internet pharmacy sales. This Comment
concludes in Part IV that while the highly sensitive nature of personal
medical information calls for a uniquely tailored law, a baseline umbrella
privacy standard should be adopted at the federal level to provide
consumers with meaningful protection and redress for all personally
identifiable information. To embrace the benefits of pharmaceutical
transactions via Internet and allow the medium to flourish, there should be
national standards for licensure, as well as continued strict enforcement for
rogue Web site operators.
II. ENHANCED AND UNIQUE CONCERNS ARISING FROM THE
INTERNET
Consumer health care delivery via the Internet has moved from an
embryonic idea to a pubescent reality. For purposes of this Comment,
health care delivery means advice and discussion between a patient and a
health care provider, access to patient and account data, and research on
drugs and diseases. Consumers should be aware that this new medium for
health care delivery presents unique and often hidden harms.
From a privacy protection standpoint, the architectural structure of the
Internet itself presents concerns because it is a global "network of
computer networks,"8 and digital information often passes through dozens
of computers before reaching its intended destination. Thus, an individual's
health care information shared over the Internet is potentially more
vulnerable to unauthorized access, distribution, disclosure, and general
misuse than if this information had simply remained in paper form in one
location. The ease with which information is created and shared over the
Internet makes this grave threat of invasion of medical privacy a very real
and constant concern in today's electronic age. When all records were
8. HARRY NEWTON, NEWTON'S TELECOM DICTIONARY 463 (16th ed. 2000). (A network
of networks essentially means that networks of all kinds-e.g. office and home networks-
around the world converge into a unified whole, the Intemet.) Id.
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maintained in paper form only and kept in the locked filing cabinet of a
single physician, it was much harder to share these records with third
parties and easier to guard against unauthorized access.
The advent of "cookie" technology,9 "Web bugs," and other tracking
software presents additional concerns unique to the Internet.0 It is not far-
fetched to imagine an environment where one's health insurance provider,
employer, or educational institution monitors the Web sites that one visits.
This would enable the insurance provider either directly or via employer
tracking to have knowledge about "risky" sites an individual visits, such as
HIV-positive support sites, cancer support sites, alcoholism support sites,
Internet gambling sites, or pornography sites. With this knowledge, the
provider may cancel coverage or simply place the individual in a higher
risk category of medical coverage. Even without any overt action, the mere
possession of this information by a third party, without disclosure or
consent, constitutes an invasion of privacy.
Internet pharmacies present a potential for abuse that is not present, or
nearly as prevalent, in traditional "bricks-and-mortar" pharmacies. The
majority of medical experts agree that the Internet today offers a
hodgepodge of useless and misleading information mixed in with very
relevant and reliable medical information." It is fair to characterize some
health information on the Internet as being delivered by the snake-oil
salespeople of the electronic age.12 For example, an Internet pharmacy may
heavily advertise a particular drug without disclosing that it is receiving a
commission from the drug's manufacturer for every online sale of that
drug. In addition, the Internet pharmacy may have chat rooms on its sites
where company representatives tout the advantages of the drug, without
disclosing their relationship to the Web site or the manufacturer. This mix
of content and commercial purpose presents a great danger to the
9. "A 'cookie' is a small piece of information sent by a web server to store on a web
browser so it can later be read back from that browser." Cookie Central, Cookies, at
http://www.cookiecentral.com/cm002.htm (last visited Jan. 24, 2001). Cookies are useful
for having the browser remember specific information, such as passwords, user IDs, e-mail
addresses, etc. Id- Cookies also enable Web site tracking. Id.
10. "Web bugs" are tiny graphic image files embedded in a Web page, generally the
same color as the background on which they are displayed, which are invisible to the naked
eye and track Internet use and system capability. See Elizabeth Weise, A New Wrinkle in
Surfing the Net, USA TODAY, June 7, 2000, available at http://www.usatoday.comlife/
cyber/tech/cth582.htm.
11. See Catherine Calacanis, Healthcare Goes Online, SHIcON ALLEY RP., Feb. 2000,
at 106, 108.
12. Reuters, Medical Experts Publish Guide to Web Medical Sites (May 11, 1999), at
http:lcnn.comnHEALTUI9905/11/health.intemetindex.html.
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unsuspecting consumer."
It might also be considerably easier to obtain prescription drugs in an
online world than in an offline environment. Consumers and Web site
operators might join together in this illegal activity. For example,
authorities recently discovered that a Web site was selling narcotics to
consumers without prescriptions or the accompanying "prescription
hassles."' 4 Such a scheme likely appeals to those who would like to obtain
strong painkillers without going through a valid prescription process.
Moreover, a rogue Internet pharmacy site may sell drugs that are not
authorized in the United States or that are counterfeit reproductions of
legally approved drugs. Consumers must be enabled to avoid known and
unknown risks and unfair business practices in their searches for
prescription drugs and other health care services on the Internet. Providing
responsible and dependable health care over the Internet requires protecting
personal health information, guarding against unauthorized surveillance of
Web site activity, empowering consumers to find reliable and credible
information and drugs via Internet pharmacies, and establishing national
licensure standards for Internet pharmacies.
A. Health Privacy
Health care information is generally considered to be among the most
intimate and sensitive of personal information. Even with this sensitivity,
health-oriented Web sites have access to an unprecedented amount of
personal information about individual consumers. For example, health-
related Web sites potentially have access to information on an individual's
personal and financial situation; physical health; family relationships;
sexual behavior; substance abuse; and private thoughts, feelings and
attitudes. Confidentiality of personal health information allows individuals
to control their most intimate details and protect against the consequences
of unauthorized disclosure, such as embarrassment, job loss, or societal
rejection. Thus, the delivery of health care services and information via the
Internet has heightened consumer fears that the confidentiality of their
personal health information will be compromised. As mentioned above,
health privacy concerns are only exacerbated by the Internet because of the
constant threat of third-party access to patient information and the
13. Calacanis, supra note 11, at 108. Consumers may not understand that certain Web
sites offering health-related advice or information are financially backed by companies
wanting to sell their health-related products and services. Thus, consumers may not know of
potential conflicts of interest. Id
14. Joanna Glasner, Narcotics: Just a Click Away?, WIRED NEWS (Feb. 1, 2000), at
http://www.wired. com/news/business/0,1367,41556,00.html.
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proliferation of surveillance technologies, such as Web bugs and cookies.
Two recent missteps highlight the problem. First, drug companies
were recently found to be paying a third-party firm, Pharmatrak, to monitor
the information consumers reviewed on the drug makers' Web sites. 5
Pharmatrak's services included, among other things, reporting to the drug
companies which computers downloaded information about HIV or a
particular prescription drug.16 While not directly identifying users
requesting this information, the company eventually plans to match the
information to user identities. 7 Second, Kaiser Permanente recently
confirmed that an e-mail glitch resulted in the unintended disclosure of
personal information. 8 Although quickly remedied, these instances provide
further evidence of the frailties of the security measures taken to protect
personal health information shared via the Internet.
Consequently, although health-related Web sites potentially provide
many societal benefits, they "have not matured enough to... guarantee the
privacy of individuals' information."' 9 To continue the growth and value of
online health care, an individual's personal health information must be
sufficiently protected from unauthorized access and disclosure, and treated
in a manner that conforms to a consumer's legitimate expectations of
privacy.
Simply creating and posting privacy policies is not enough. Even
when Web sites purport to offer strong privacy protections, they may
ignore their own policies. The California HealthCare Foundation sponsored
a study released on February 1, 2000, showing that many online health care
sites do not follow their own privacy policies, and, in some cases, share
health information about visitors with third-party business partners. °
Facilitating an environment where consumers can have confidence that
their intimate and sensitive personal health information will be protected
and not disclosed unless authorized is necessary to the future viability of
health care delivery via the Internet.
15. Robert O'Harrow, Jr., Drug Companies Pay Firm to Track Consumers on Web,
L.A.TIMES, Aug. 17,2000, at Cl.
16. Id
17. Id. ("'In the future, we may develop products and services which collect data that,
when used in conjunction with the tracking database, could enable a direct identification of
certain individual visitors."')
18. Meghan Holohan, Kaiser E-mail Glitch Releases Patients' Private Information,
COMPUTERWORLD (Aug. 10, 2000), available at http://www.computerworld.com
cwi/story/0,1199,NAV47_ST048407,00.html.
19. JANLORi GOLDMAN ET AL., CALIFORnA HEALTHCARE FOUND., PRIVACY: REPORT
ON THE PRIVACY POLICIES AND PRACICES OF HEALTH WEB SITES 3 (2000), available at
http://admin.chcf.orgldocuments/ehealth/privacywebreport.pdf (last visited Jan. 24, 2001).
20. Id. at 4.
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B. Internet Pharmacy Sales
The sale of prescription drugs over the Internet has the potential to
offer many societal benefits. For example, Internet sales of prescription
drugs can foster price competition and facilitate access for the elderly and
those in rural areas.21 Internet pharmacies may generally be divided into
three groups: those that merely provide a limited number of select drugs;
those that are created from existing bricks-and-mortar pharmacies; and
those that offer full service virtual pharmacies (e.g., drugstore.com). 22
Many pharmaceutical companies also have Web sites that provide
consumer and professional information. 2' Advertisements on television,
radio, and in print often direct consumers to manufacturer Web sites, which
offer additional avenues for prescription drug promotion. Thus, the Internet
offers a new means for consumers to gain knowledge about medical
products and services and efficiently and economically obtain these
products and services.
As in the medical privacy arena, online prescription drug sales present
great potential for abuse. Such abuse can occur at both the vendor and
consumer levels. For example, online vendors may sell counterfeit drugs,
or fail to require prescriptions before distributing drugs, or consumers may
supply counterfeit prescriptions to online vendors. To counter these risks,
the health care industry must carefully guard against abuse and
unauthorized use of various drugs, and consumers must be ensured
complete, truthful disclosure about prescription medications.
The Internet provides an opportunity to circumvent strict procedural
safeguards set in place to protect against both vendor and consumer abuse.
Anonymity in transactions poses great risks to consumers. For example,
Web-savvy entrepreneurs could establish Web sites and begin selling
counterfeit drugs. Eventually, such illegal activity could be stopped; no one
knows just how long it would take to discontinue the commerce, however,
or how many consumers would be affected by such rogue Web site
activity. Conversely, without concrete security measures, consumers could
theoretically provide a single prescription to several online pharmacies to
obtain additional medication, or no prescription at all to willing Web sites.
Another unique concern in the online medium is the mixture of
21. Hearings, supra note 2, at 87 (testimony of Ivan Fong, Deputy Assoc. Att'y Gen.,
Dep't of Justice).
22. Canadian Pharmacists Ass'n, Statement on Internet Pharmacy in Canada (Feb.
2000), at http://www.cdnpharm.ca/cphanew/HotStuff/hsframel2.htm (last visited Feb. 2,
2001) [hereinafter Canadian Pharmacists Ass'n].
23. Examples of such company Web sites include Merck (www.merck.com), Pfizer
(www.pfizer.com), and Lilly (www.lilly.com).
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medical content with advertising in a manner that suggests that the
advertising is actually medical advice from a health care practitioner.24 In
the offline world, there are usually clear distinctions between a pharmacy
and pharmaceutical manufacturer.25 In the online world, however, a
medical practitioner employed by a Web site may tout a particular drug
simply because the drug's manufacturer pays for the promotion. This
information is unknown to the Web site visitor and could lead to consumer
deception.
1I. EXISTING LEGAL FRAMEWORKS
Health care Web site owners and operators should not be able to
escape the imposition of existing laws that apply to traditional bricks-and-
mortar health care establishments. Recognizing the general applicability of
existing laws to Internet health services is a necessary first step in defining
and determining the scope and character of protections afforded to Internet
health consumers and the requirements of Internet health care delivery
services.
A. Informational Health Privacy
In the United States and Canada, informational health privacy is
regulated at both the federal and state/province/territory levels.
1. United States
The United States has a federal system of government. Each of the
fifty states has its own governmental system complemented by a national
governmental framework covering the entire nation. In the context of
health care services over the Internet, therefore, any such enterprise must
comply with both national and state laws.
The primary enforcement mechanism for federal laws in the United
States is the Department of Justice ("DOJ"). The DOJ's mission includes
"enforc[ing] the law and defend[ing] the interests of the United States. '26 In
addition, the Federal Trade Commission ('"FTC" or "Commission")
enforces a variety of consumer protection laws as well as a number of
competition-promoting laws. The FTC's consumer protection mission
involves eliminating deceptive or unfair acts from the marketplace.27 Under
24. See Calacanis, supra note 11, at 108.
25. Nicholas P. Terry, Cyber-Malpractice: Legal Exposure for Cybermedicine, 25 Am.
J.L. & MED. 327, 329 (1999).
26. DOJ, ANNUAL ACCOUNTABLITY REPORT: FIscAL YEAR 1999, at v. (2000), available
at http:llwww.usdoj.gov/aglannualreportstar99/index.html (last visited Jan. 24, 2001).
27. FTC, Vision, Mission & Goals, at http:llwww.ftc.gov/ftclmission.htm (last
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the Federal Trade Commission Act ("FTC Act"), the FTC is empowered to
prevent unfair methods of competition and "unfair or deceptive acts or
practices in or affecting commerce,, 28 prescribe trade regulation rules
defining acts that are unfair or deceptive, and establish requirements
designed to prevent such acts or practices.29 As a result, one of the
Commission's major policy initiatives since 1995 has been to address
online privacy.
The Internet has experienced widespread growth since 1990. From
1990 to 1997, the "estimated number of Internet users grew from around
one million to around 70 million."3' Thus, the Clinton Administration was
the first to play a key role in formulating Internet policy. To facilitate the
growth of the Internet and electronic commerce, the Clinton
Administration developed a general policy that "includes support for
industry self-regulation where possible, technology-neutral laws and
regulations, and an appreciation of the Internet as an important medium...
for commerce.' 32 This policy has helped to facilitate the dramatic and
widespread adoption of the Internet as a valuable communications,
information, and electronic commerce medium.
a. Federal law
The Internet has fueled interstate commerce, which in turn has
produced a growing body of laws with provisions covering the
confidentiality of medical records and information. Most federal laws
merely address the handling of personally identifiable health information
by federal agencies and their private subcontractors. For example, the
Privacy Act of 1974 provides a system of confidentiality protections that
modified June 17, 1999).
28. 15 U.S.C. § 45(a)(1) (1994).
29. Id. §§ 41-58.
30. In the fall of 1995, the FTC held extensive hearings on the implications of
globalization and technological innovation for both competition and consumer protection.
The hearings were summarized in a staff report entitled ANTICIPATING THE 21ST CENTURY:
CONSUMER PROTECTION POLICY IN THE NEw HIGH-TECH, GLOBAL MARKETPLACE (1996),
available at http://www.ftc.gov/opp/globalreportgcqvl.pdf (last visited Jan. 24, 2001).
Since that time, the Commission has produced four reports on the subject of online
information collection practices. The FTC released the latest report in May 2000. FTC,
PRIVACY ONLINE: FAIR INFORMATION PRACTICES IN THE ELECTRONIC MARKETPLACE A
REPORT TO CONGRESS (May 2000), available at http://www.ftc.gov/reports/privacy2000/
privacy2000.pdf (last visited Jan. 24, 2001) [hereinafter PRIVACY ONLINE]
31. THE MANAGEMENT OF INTERNET NAMES AND ADDRESSES: INTELLECTUAL PROPERTY
ISSUES: FINAL REPORT OF THE WIPO INTERNET DOMAIN NAmE PROCESS para. 2(i) (1999),
available at http://wipo2.wipo.int/processl/report/pdf/reporLpdf (last visited Jan. 24, 2001).
32. Hearings, supra note 2, at 87 (testimony of Ivan Fong).
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apply to individual records, including medical histories,3 when that
information is retained by federal agencies.34 Other federal statutes have
been used to address at least some medical records issues. These include
the Health and Human Services ("HHS")-sponsored statute to require
Medicare + Choice organizations to establish safeguards for maintaining
the privacy of health information;35 the Inspector General Act of 1978,
which authorizes the Inspector General's office to access records,
documents, and other materials for its purposes;36 the Americans with
Disabilities Act;37 the Controlled Substances Act;38 and the Comprehensive
Alcohol Abuse & Alcoholism Prevention, Treatment & Rehabilitation Act
of 1970.29
1. Department of Health and Human Services
In August of 1996, former President Clinton and Congress took an
important step toward regulating the conduct of private actors by enacting
the Health Insurance Portability and Accountability Act of 1996
("HIPAA"). 40 One of the primary purposes of HIPAA was to facilitate the
41
electronic storage and distribution of health information. In addition,
HIPAA was intended to address the "need for national standards to control
the flow of sensitive patient information and to establish real penalties for
the misuse or disclosure of this information.' 42 Toward this end, HIPAA
gave HHS the authority to promulgate binding regulations on the use of
personally identifiable health information in certain transactions if
Congress failed to enact medical confidentiality legislation by August 21,
1999.43 After this deadline passed without any such federal legislation,
HHS issued a proposed Health Information Privacy Rule on November 3,
33. 5 U.S.C. § 552a(a)(4) (1994).
34. Privacy Act of 1974, Pub. L. No. 93-573, § 2(b), 88 Stat. 1896, 1897.
35. Balanced Budget Act of 1997 § 4001, 42 U.S.C. § 1395w-22(h) (Supp. IV 1998).
36. Inspector General Act of 1978, 5 U.S.C. app. § 6 (1994).
37. 42 U.S.C. § 12112(d)(3)(B).
38. 21 U.S.C. § 872(c).
39. 42 U.S.C. § 290dd-2, amended by 42 U.S.C. § 290dd-2(e) (Supp. IV 1998).
40. The Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), Pub.
L. No. 104-191, 110 Stat. 1936 (codified at scattered sections of 26, 29, and 42 U.S.C.).
41. DEP'T OF HEALTH AND HuMAN SERvs., IMPLEMENTATION OF ADMIaSTRATIVE
SIMPLIFICATION REQUIREMENTS BY HIS, at http:llaspe.os.dhhs.gov/admnsimplkldmpl.htm
(last updated Aug. 24, 1998).
42. DEP'T OF HEALTH AND HUMAN SERvs., HHS FAcT SHEET, PROTECTING THE
PRIVACY OF PATIENTS' MEDICAL REcoRDs (2000), available at http://www.hhs.gov/
news/press/2000pres/00fsprivacy.html (last visited Feb. 5, 2001) [hereinafter HIS FACT
SHEET].
43. Id.
FEDERAL COMMUNICATIONS LAW JOURNAL
1999." On December 20, 2000, the HHS Secretary announced the final
regulations ("Privacy Rule"), which became effective on February 26,
2001.45
In the view of the HHS Secretary, the key principles necessary in a
federal privacy law were consumer control, accountability, public
responsibility, boundaries, and security.46 In fulfilling these principles, the
Privacy Rule establishes a set of basic national privacy standards and fair
information practices that protect Americans' personally identifiable health
information.47 Specifically, it: (1) ensures patient access to their medical
records; (2) requires patient consent before individually identifiable health
information is used and shared for purposes of treatment and payment; (3)
establishes fair information practices to inform patients how their personal
information is used and disclosed; (4) requires safeguards to protect
confidentiality and prevent unauthorized access; and (5) establishes
penalties for misuse of personal health information. 4
In giving patients greater access to and control over their personal
health information and providing boundaries for use and security of that
information, the Privacy Rule directly applies only to health plans, health
care clearinghouses, and health care providers who transmit health
information in electronic form ("covered entities") in their use and
disclosure of "protected health information.' 9  "Protected health
information" is defined as "individually identifiable health information"
regardless of its form or format. ° In certain situations, the Privacy Rule
also applies to a covered entity's business associates. While business
associates retained by covered entities (lawyers, accountants, consultants,
etc.) to perform certain services are not directly covered by the Privacy
Rule, covered entities must contractually require the protection of protected
health information when business associates have the right to use or
disclose the protected health information belonging to the covered entity.5'
44. See 64 Fed. Reg. 59,917 (Nov. 3, 1999).
45. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462 (Dec. 28, 2000) (codified at 45 C.F.R. pts. 160, 164).
46. "Boundaries" indicate that generally an individual's health care information is to be
used for health purposes only. HHS FACT SHEET, supra note 42.
47. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
at 82,463-74.
48. HHS FAT SHEET, supra note 42.
49. Standards for Privacy of Individually Identifiable Health Information, 45 C.F.R. §
160.102(a). Under HIPAA section 1171(a), only these three entities could be covered under
a final privacy rule. The Health Insurance Portability and Accountability Act of 1996 §
1171(a), 42 U.S.C. § 1320d (Supp. IV 1998).
50. 45 C.F.R. § 164.501 (2001).
51. Id. §§ 160.103, 164.502(e)(2).
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The Privacy Rule places meaningful limits on the flow of protected
information. For instance, a covered entity must make all reasonable efforts
not to use or disclose more than the minimum amount of protected
information necessary to accomplish the intended purpose. 52When use or
disclosure of protected health information is necessary, a covered entity
must generally obtain the individual's consent before using this
information to carry out treatment, payment, or health care operations.53
Additionally, covered entities are encouraged to use "de-identified"
information, stripped of elements that could be used to identify
individuals.- Once information has been "de-identified," it may be used or
disclosed without restriction . 5 Finally, the Privacy Rule restricts employer
56
access to information for purposes other than health care.
While the Privacy Rule represents the first comprehensive federal law
that protects the confidentiality of personally identifiable health
information, it has some gaps in its protection. First, there is no private
right of individual action for inappropriate use of medical data. 7 A private
right of action is important because it gives consumers direct redress for
harms to their personal privacy. In addition, a private right of action
encourages consumers to be more vigilant guardians of their sensitive
medical information, whereas the Privacy Rule encourages more
unauthorized activity with less public monitoring and safeguarding.
Second, HHS does not have authority to issue standards for records
maintained by other insurers, employers, or schools because the "coveredS 51
entities" section limits the specific entities governed by the requirements.
Third, the Privacy Rule does not directly place restrictions on the use or
disclosure of information by business associates.59 Fourth, covered entities
52. /d § 164.502(b)(1).
53. Id § 164.506(a).
54. Id § 164.502(d).
55. Id.
56. Id § 164.512(b)(1)(v).
57. This defect results from the fact that Congress did not authorize such an
enforcement mechanism. Nonetheless, HIPAA does provide for civil penalties for a failure
to comply with the requirements and standards, and criminal penalties for certain wrongful
disclosures. The Health Insurance Portability and Accountability Act of 1996 §§ 1176,
1177,42 U.S.C. 1320d-5 (Supp. IV 1998).
58. 45 C.F.R. § 160.102. Again, this defect is a result of HIPAA's statutory limits.
59. This fourth element is noteworthy because of the recent public outcry concerning
DoubleClick's (a third party business partner to many health care Web sites) use of targeted
promotional messages. Recently, a California woman filed a lawsuit against the company
alleging violation of privacy rights and deceptive practices. Allegedly, she received a
barrage of unsolicited e-mails from insurers, loan companies, and others after she looked up
medical insurance information online. Heather Green et al., Privacy: Outrage on the Web,
Bus. WK., Feb. 14, 2000, at 38. If business partners and all holders of personally
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are permitted to disclose protected health information to law enforcement
officials pursuant to administrative subpoenas or summons without
independent judicial review.60
Perhaps most relevant to this Comment, the majority of health care
Web sites may not meet the statutory definition of "covered entities" under
the proposed Privacy Rule, and will therefore not be subject to its•61
requirements. Nonetheless, it is likely that many health care Web sites
have business plans to eventually offer or support services that make them
"business associates" of health plans or health care providers for the
purposes of the regulation. To the extent that this occurs, it will be
imperative that health care Web sites demonstrate to their covered entity
business associates that their privacy policies, data handling practices and
procedures, business arrangements with third parties, personnel
management, and technical security arrangements meet or exceed the
62
standards of the Privacy Rule.
2. Federal Trade Commission
In addition to the above detailed medical privacy law, the FTC is
responsible for enforcing the nation's consumer protection laws, which
63protect consumers from deceptive trade practices.
As mentioned above, the FTC has focused considerable attention and
resources on issues related to the collection and dissemination of personal
information on the Internet. In its 2000 report, Privacy Online: Fair
Information Practices in the Electronic Marketplace, the FTC stated that
the "failure to comply with stated information practices may constitute a
identifiable information are not directly restricted in use and disclosure by the Privacy Rule,
more assaults on sensitive medical information will occur.
60. 45 C.F.R § 164.512(f)(1)(ii)(C). Other warrants and nongrand jury subpoenas or
summons require independent judicial review. Id. § 164.512(f)(1)(ii)(A).
61. Id. § 160.102. The closest definition to a health care Web site is a health care
provider. The Privacy Rule defines "health care provider" as the Social Security Act does in
42 U.S.C §§ 1395x(u): a provider of services, meaning a "hospital, critical access hospital,
skilled nursing facility, comprehensive outpatient rehabilitation facility, home health
agency, hospice program;" and in § 1395x(s) as a provider or medical or health services,
such as physician, hospital and diagnostic services; and also as "any person or organization
who furnishes, bills, or is paid for health care services in the normal course of business." 45
C.F.R § 160.103. This definition likely includes researchers who provide health care to
research subjects, free clinics, and health clinics or licensed health care professionals
located at schools or business.
62. This includes providing "satisfactory assurances that the business associate will
appropriately safeguard information. 45 C.F.R. § 164.502(e)(1)(i).
63. See 15 U.S.C. §§ 41-58 (1994). Specifically relevant in the privacy context, section
5(a) of the FTC Act prohibits "unfair or deceptive acts or practices in or affecting
commerce." Id. § 45(a).
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deceptive practice ... and the Commission has authority to pursue the
remedies available under the Act for such violations."'4
The FTC has used its authority under section 5 of the FTC Act to
prosecute companies whose practices do not live up to the privacy policies
posted on their Web sites.6 Health care Web sites can be prosecuted under
section 5 of the FTC Act for violations of their privacy policies because the
FTC does not treat health care Web sites differently than any other Web
sites. In addition to enforcing privacy policies, the FTC has examined the
role of self-regulation, technology-based privacy solutions, and the special
66
case of children's privacy. The Commission has recently endorsed a self-
regulatory framework developed by the Network Advertising Initiative,67
68
while at the same time calling for baseline privacy legislation.: While
continuing to encourage online privacy through self-regulation, the FTC
believes that a stopgap legislative measure is necessary to fully ensure that
69
consumer privacy is protected online.
The legislation envisioned by the Commission in its report to
Congress on online profiling would "set forth a basic level of privacy
protection for all visitors to consumer-oriented commercial Web sites with
64. PRIVACY ONLINE, supra note 30, at 34.
65. The FrC has brought cases against several companies that failed to follow their
own privacy policies. See id. at 42 (stating that FrC has brought cases against GeoCities,
Liberty Financial and ReverseAuction); FTC, FTC Sues Failed Website, Toysmart.com for
Deceptively Offering for Sale Personal Information of Website Visitors (July 10, 2000), at
http://www.ftc.gov/opa/2000/O7/toysmart.htm; FTC, Online Pharmacies Settle FTC
Charges (July 12, 2000), at http://www.ftc.gov/opa/2000/07log.htm.
66. PRIVACY ONLINE, supra note 30, at 42 n.21. Based on survey research showing that
Web sites that target children often collected information, the FrC concluded that
legislation was necessary to protect the online privacy of children. Id. at 4. Congress
responded by passing the Children's Online Privacy Protection Act ("COPPA"), 15 U.S.C.
§§ 6501-6506 (Supp. IV 1998).
67. Formally announced at the Department of Commerce/FrC Public Workshop on
Online Profiling, held November 8, 1999, Network Advertising Initiative is an organization
comprised of leading Internet advertisers. Network Advertising Initiative, Testimony at the
Online Profiling Workshop, at http:llwww.networkadvertising.orglpressll 1-9-99testimony.
shtml (last visited Jan. 27, 2001).
68. FrC, ONLmE PROFmING: A REPORT TO CONGRESS PART 2 RECOMMENDATIONS 4
(2000), available at http:lwww.ftc.gov/os/2000/07/onlineprofiling.pdf (last visited Jan. 27,
2001).
69. See id. at 9-10. Commissioner Orson Swindle disagreed that legislation was needed
as a backstop and therefore dissented from this recommendation. He characterized
legislation mandating the four fair information practices (notice, choice, access, and
security) as overly burdensome and unwarranted. Id. cmt. (Dissenting Statement of Comm'r
Swindle). Commissioner Thomas Leary agreed that some legislation was needed but
suggested that legislation focus on adequate notice and not across-the-board standards for
fair information practices. Id. cmt. (Statement of Comm'r Leary Concurring in Part and
Dissenting in Part).
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respect to profiling."70 The FTC suggests that such legislation provide an
implementing agency with the authority to: (1) promulgate more detailed
standards; (2) enforce those standards; and (3) grant safe harbors to self-
regulatory principles that effectively implement the standards of fair
information practices detailed in the legislation and subsequent
rulemaking.7'
b. State law
Individual states currently provide a patchwork of laws and
regulations addressing health care information and records. In the most
comprehensive study of state health privacy laws to date, the Georgetown
Health Privacy Project noted that "[s]tate laws relating to health privacy
have been enacted at different points in time, over many years, and address
a wide variety of uses and public health concerns. 72 Nonetheless,
providing health services over the Internet is a multi-jurisdictional activity
that could, in theory, implicate the laws of all fifty states.
Moreover, HI-S's Privacy Rule under HIPAA does not necessarily
preempt state law.73 Instead, the federal standards under HIPAA are
intended to enhance the privacy protections offered in existing state laws.74
Where state and federal laws relating to the privacy of personally
identifiable information conflict, the stronger privacy protection will
prevail.75 Lastly, individual states are also free to enact more stringent
standards and requirements with respect to disclosure or the rights of
76individuals to access or amend their individually identifiable information.
70. Id. at 10.
71. Id.
72. HEALTH PRIVACY PROJECT, GEORGETOWN UNIVERSITY INSTITUTE FOR HEALTH CARE
RESEARCH AND POLICY, THE STATE OF HEALTH PRIVACY: AN UNEVEN TERRAIN, Executive
Summary (1999), at http://www.healthprivacy.org/usrdoc/33779.pdf (last visited Feb. 1,
2001).
73. Standards for Privacy of Individually Identifiable Health Information, 45 C.F.R. §
160.201 (2001). This limitation is due to the language in section 1178 of HIPAA. Health
Insurance Portability and Accountability Act of 1996 § 1178, 42 U.S.C. § 1320d-7 (Supp.
IV 1998).
74. As a general rule, state laws that are contrary to standards or implementation
specifications, such as those under the Privacy Rule, are preempted. 42 U.S.C. § 1320d-7.
The statute provides an exception to this preemption for state laws that are more stringent
than the federal requirements. Id.
75. Health Insurance Portability and Accountability Act of 1996 § 264(c)(2), 110 Stat.
at 2033; see also Standards for Privacy of Individually Identifiable Health Information, 64
Fed. Reg. 59,922 (Nov. 3, 1999) (explaining that section 264's preemption provision
provides that "contrary provisions of State laws that are more stringent than the federal
standards, requirements, or implementation specifications will not be preempted").
76. 45 C.F.R. §§ 160.202, 160.203(b).
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This is because the Privacy Rule is intended to establish a floor, not a• - 77
ceiling, on privacy protections.
A seminal case on the ability of states to collect personally
identifiable information as it relates to use of prescription drugs of a certain
caliber (e.g., drugs having a potential for abuse and also a recognized
78
medical use) is the Supreme Court case of Whalen v. Roe. The New York
statute at issue required physicians to provide the New York State
Department of Health in Albany with prescription information, which was
then recorded in a centralized computer file.79 In Whalen, the Court
reversed a decision by the District Court for the Southern District of New
York, and held that: (1) the personally identifiable requirement was a
reasonable exercise of the state's broad police powers;80 (2) the statute, on
its face, was not an invasion of the right to privacy or any other right or
liberty protected by the Fourteenth Amendment;1 and (3) the statute did
not impair the physician's right to practice medicine free of state
interference.8 2
In denying the privacy interest, the Court reasoned that the security
provisions in New York's statute prohibiting public disclosure of the
personally identifiable information would be properly administered 3 In
addition, the Court reasoned that disclosure of the private information to
authorized employees did not automatically amount to an impermissible
invasion of privacy.84 The Court was careful to limit its holding to the
record before it, however, and noted that this record by itself did not
constitute an invasion of the liberties protected by the Fourteenth
Amendment. 5 Thus, a different set of facts, such as when protection of an
individual's interest in privacy is not adequately guarded, might cause
enough concern for the Court to overrule a similar state statute. The
Whalen case is important because it shows that although many state laws
carry good privacy protections, states have broad authority to enact laws
that infringe on medical privacy interests under the constitutional guise of
their police powers.
77. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. Reg.
82,462, 82,463-74 (Dec. 28,2000).
78. 429 U.S. 589 (1977).
79. Id. at593.
80. Id. at598.
81. Id. at 600.
82. Id. at 604.
83. Id. at 601.
84. Id. at 602.
85. Id. at 605-06.
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2. Canada
In contrast to the United States, Canada has a parliamentary system of
government. In each of Canada's ten provinces, there is a legislature, and
for every province except Ontario, there is an appointed Upper House-the
Legislative Council-and an elected Lower House-the Legislative
Assembly. Like the United States, Canada operates under a federalist
system. This includes a strong central government and Parliament,
combined with an ample measure of autonomy and self-government for
each of the federated communities.86
Canada's constitution, unlike that of the United States, incorporates
many documents.8' The Constitution Act of 1982 sets out the Canadian
Charter of Rights and Freedoms.' The rights guaranteed by the Charter are:
(1) fundamental freedoms (conscience, religion, thought, belief, opinion
and expression, peaceful assembly, and association); (2) democratic rights;
(3) mobility rights; (4) legal rights; (5) equality rights; (6) official language
rights; and (7) minority language education rights in certain
• 89
circumstances. All these rights are "subject only to such reasonable limits
... as can be demonstrably justified in a free and democratic society."90
a. Federal law
Like the United States, Canadian federal privacy law addresses the
handling of personal health information by federal agencies and their
private subcontractors. The Canadian Privacy Act ("Privacy Act") gives
Canadian citizens and people present in Canada the right to have access to
information about them held by any listed "department or ministry of state
of the government of Canada."91 Because Canada offers a single-payer
92system of health care, some government operations use personal
86. Canada's ten provinces are Alberta, British Columbia, Prince Edward Island,
Manitoba, New Brunswick, Nova Scotia, Ontario, Quebec, Saskatchewan, and
Newfoundland and Labrador. Canada's three territories include the Northwest Territories,
Nunavut, and the Yukon Territory. Government of Canada, Canada, at
http://canada.gc.ca/canadiana/lmap-e.html (last visited Jan. 27, 2001).
87. Canadian Embassy, Canada's Constitution, available at http:Ilwww.
canadianembassy.orglissues/federalism/constitution.html (last visited Jan. 27, 2001).
88. CAN. CONST. (Constitution Act, 1982) pt. I (Canadian Charter of Rights and
Freedoms), §§ 2-23.
89. Id.
90. Id. § 1.
91. Privacy Act, R.S.C., ch. P-21, §§ 2-3 (1985) (Can.).
92. This is not to be confused with a "socialized medicine" system in which doctors are
employed by the government. Canada's system involves private practitioners who are
generally paid on a fee-for-service basis. Canadian provinces and territories plan, finance,
and evaluate hospital care, physician services, and some aspects of prescription care and
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information about individuals, such as health promotion programs at
Health Canada&3 and income tax programs at Revenue Canada.94 In addition
to the right of access, individuals may request that any errors be corrected
and, if a request is refused, require that a notation be attached to the
information describing any corrections requested but not made.95 The
Privacy Act also protects against unauthorized disclosure of personal
information." In addition, the Privacy Act strictly controls how the
government will collect, use, store, disclose, and dispose of any personal
information.97
The Privacy Act requires the federal government to: (1) limit its
collection of personal information to the minimum details needed to
operate programs or activities; (2) collect the information, whenever
possible, directly from the person concerned; (3) tell the person why the
information is being collected and how it will be used; (4) not use the
information for other purposes, unless allowed by law; (5) keep the
information long enough to allow the person a reasonable opportunity to
obtain access; (6) ensure the information is as accurate, up-to-date and
complete as possible; and (7) not disclose personal information unless
specifically allowed by the Privacy Act or another law.9 Since the Privacy
Act took effect, Canadians have enjoyed a right to privacy with respect to
their health information and federal government records. 99 While the
medical records themselves belong to the physician, patients are entitled to
examine and copy all of their medical records.' °°
In addition to the protections afforded by the Privacy Act, in August
1998, the Canadian Medical Association approved the Health Information
Privacy Code ("CMA Code"), which offers an industry self-regulatory
mechanism for protecting personal health information.01 The CMA Code
public health. This is the single-payer system. Health Canada, About Health Canada, at
http://www.hc-sc.gc.catenglish/about.htm (last visited Jan. 27, 2000).
93. Id. Health Canada is the federal department responsible for developing health
policy, enforcing health regulations, promoting disease prevention and enhancing healthy
living for all Canadians. Ia Health Canada ensures that health services are available and
accessible to Canadian citizens. Id
94. Canada Revenue and Customs Agency, Who We Are, at http://www.ccra-
adrc.gc.ca/agency/menu-e.html (last visited Jan. 27, 2001). Revenue Canada is the federal
department responsible for tax, trade, and border legislation and regulations. Ia
95. Privacy Act, R.S.C., ch. P-21, § 12(1)-(2) (1985) (Can.).
96. Id. § 8(1).
97. Id. §§ 4-6.
98. Privacy Act, R.S.C., ch. P-21, §§ 4-8(1) (1985) (Can.).
99. Id.
100. McInemy v. MacDonald, [1992] 2 S.C.R. 138 (establishing a common law right of
access to one's own medical records).
101. Canadian Medical Ass'n, CMA Health Information Privacy Code, at
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articulates principles for protecting "the privacy of . . .patients, the
confidentiality and security of. . .health information and the trust and
integrity of the therapeutic relationship," and "applies to all health
information and to all individuals, groups or organizations that collect, use,
disclose or access such information."'02 Although this CMA Code is
noteworthy because it sets standards and creates awareness of the
importance of confidentiality of personal medical information, it lacks
effective enforcement mechanisms. 13 Because the CMA Code is a self-
regulatory program, health custodians subject to it must merely subscribe
to the principles and agree to uphold them; the CMA Code does not
provide for further enforcement for violations or tracking.'l 4
Possibly the biggest hole in Canadian privacy protections was the
lack of a general privacy law applicable to private actors. The Internet and
the explosion of electronic commerce have unequivocally pointed to the
need for stronger privacy protections from unaccountable private actors.
The Government of Canada responded to this need. In October 1998, the
Personal Information Protection and Electronic Documents Act ("PIPED
Act") was introduced in the House of Commons, °5 and it was enacted on
April 13, 2000.106
The PIPED Act introduced measures to protect personal information
in the private sector, created an electronic alternative for doing business
with the federal government, and clarified how courts assess the reliability
of electronic records used as evidence. 1° The PIPED Act will apply to all
organizations that collect, use, or disclose personal information.'08 Thus,
theoretically, this bill could apply to both domestic and foreign
organizations.
Beginning January 1, 2002, with a few exceptions, any federally
regulated industry organization that uses, collects, or discloses personally
identifiable information in the course of commercial activity, must protect
that information by complying with a set of ten principles based on the
Canadian Standards Association's Model Privacy Code for the Protection
http://www.cma.ca/inside/policybase/1998/09-16.htm (last visited Jan. 27, 2001).
102. Id. § A.
103. See id.
104. See id.
105. Bill C-6, Personal Information Protection and Electronic Documents Act, 2d. Sess.,
36th Parl., 1999, available at http:/www.parl.gc.ca/36/2/parlbus/chambus/house/bills/
government/C-6/C-6_4/C-6TOCE.html.
106. Personal Information Protection and Electronic Documents Act, S.C., ch. 5 (2000)
(Can.).
107. Id.
108. Id. § 3.
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of Personal Information ("Model Code").'0 9 The law Will not apply to
organizations that handle personal health information for commercial
purposes until January 1, 2002.0 On January 1, 2004, the law will extend
to all non-federal businesses that handle personal information for
commercial purposes.' Organizations that handle information for
journalistic, artistic, law enforcement, and specifically non-commercial
purposes are exempt from the law, as are individuals who handle




The Model Code's ten principles, which are given legal effect by their
incorporation into Schedule 1 of the PIPED Act,13 require covered entities
to ensure accountability for complying with the provisions; identify
purposes for collecting personal information; obtain consent for such
collection; limit the amount of data collected to only what is needed; limit
the subsequent use, disclosure, and retention of the collected information;
ensure the information's accuracy; institute safeguards to protect the data
collected; make data collection and maintenance policies readily available;
allow individuals to access their own data; and accept and address
individual challenges regarding the entity's compliance with the
provisions." 4 An individual who suspects that an organization is not in full
compliance with the privacy protection principles and cannot settle the
matter with that organization may then bring a case before Canada's
Privacy Commissioner, who will seek to resolve the dispute."- Unresolved
disputes will be taken before the Federal Court, which may order the
organization to correct its practices and award damages to the complainant,
including damages for "humiliation that the complainant has suffered."".6
In addition, anyone found guilty of obstructing an investigation by the
Commissioner may be fined up to $100,000."
7
Where a province or a territory adopts substantially similar
legislation, the organizations covered by the provincial or territorial
legislation will be exempted from the application of the federal law within
109. Industry Canada, Electronic Commerce in Canada, Privacy: The Protection of
Personal Information, at http://www.ecom.ic.gc.ca/englishlprivacy/632d30.html (last
visited Jan. 27, 2001) [hereinafter Protection of Personal Information].
110. Id.
111. Id.
112. Personal Information Protection and Electronic Documents Act, S.C., ch. 5, § 4
(2000) (Can.).
113. Protection of Personal Information, supra note 109.
114. Personal Information Protection and Electronic Documents Act, S.C., ch. 5, sch.1,
§ 4 (2000) (Can.).
115. Id. § 11(1).
116. Id. §16(c).
117. Id. §28(b).
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that jurisdiction."' Quebec already has substantially similar privacy
legislation covering the private sector, so organizations collecting, using, or
disclosing personal information within the province will be exempted from
the application of the federal bill. 9 The federal legislation complements
Quebec's private sector privacy law by covering federally regulated
organizations such as banks and airlines, as well as interprovincial and
international data flows.
20
b. Province and Territory law
The individual provinces in Canada have enacted their own privacy
laws. Unlike laws enacted by the individual states in the United States,
these laws generally cover personal information in hospitals, mental health
centers, health units, and student/employee health centers located in
provincial or local government offices or post-secondary institutions.
These medical facilities are government-provided services and thus subject
to existing privacy laws applicable to government actors-not because
private physician services fall subject to privacy legislation.
The Canadian province of Quebec stands as an exception to this, as it
122has enacted privacy legislation applicable to private actors. Thus, in
Canada, there is not only a chasm between health privacy regulations
covering government and private actors, but each province differs in the
specific privacy protections afforded to its citizenry.12 Nonetheless, much
of the existing and new legislation has been criticized as empowering
provincial governments to "breach patient-physician privacy by allowing
118. Protection of Personal Information, supra note 109.
119. In January 1994, Quebec enacted Bill 68, which extended the right of access to
personal information held by credit bureaus, insurance companies, pharmacies, and any
other commercial enterprises that hold personal information. See An Act Respecting the
Protection of Personal Information in the Private Sector, S.Q., ch. 17 (1993) (Can.).
120. Personal Information Protection and Electronic Documents Act, S.C., ch. 5, § 2(1)
(2000) (Can.).
121. See Freedom of Information and Protection of Privacy ("FOIP") Act, S.A., ch. F-
18.5 (1994) (Can.) (aiming to strike a balance between the public's right to know and the
individual's right to privacy, as these rights relate to information held by the Government of
Alberta). Ontario and British Columbia have also adopted Freedom of Information and
Protection of Privacy Acts. See Freedom of Information and Privacy Act, R.S.O., ch. F.31
(1990) (Can.); Freedom of Information and Privacy Act, RS.B.C., ch. 165 (1996) (Can.).
122. See An Act Respecting the Protection of Personal Information in the Private Sector,
S.Q., ch. 17 (1993) (Can.).
123. See Miro Cernetig, Drug Company Sues to Obtain B.C. Data, THE GLOBE AND
MAIL (Apr. 3, 1998), at A10, available at http://ptg.djnr.comlccrootlasp/publib/story.asp.
The British Columbia "government's decision to stop pharmacies from selling information
about drug sales to the private sector [was] challenged in the B.C. Supreme Court." Id
Right now, British Columbia is the only province in Canada that prohibits pharmacists from
providing detailed data on drug sales to companies. Id
[Vol. 53
Number 2] PHARMACEUTICAL SALES ON THE INTERNET
them and others to access electronic health records."124
In January of 1998, Industry Canada2 5 issued a discussion paper
entitled "The Protection of Personal Information: Building Canada's
Information Economy and Society.' 26 The paper requested public
comment concerning the specific structure and function of proposed federal
legislation to regulate the collection, use, and disclosure of personal
information in the private sector. 27 In response to this request, British
Columbia's Privacy Commissioner made a number of recommendations,
including: (1) that the Government of Canada and the provincial
legislatures introduce statutory privacy rights for the protection of personal
information held by private actors; (2) that this legislation establish a
statutory requirement of informed consent; and (3) that this legislation
further establish enforceable legal rights to fair information practices.
Thus, like their American counterparts, many Canadian citizens have
expressed a desire for a uniform statutory response to address the privacy
of personally identifiable information on the Internet.
3. Analysis of Informational Health Privacy Laws in the United
States and Canada
a. Similarities
Until recently, there were two primary similarities between the laws
in the United States and Canada. First, both countries offered a patchwork
of privacy protections that differed from state to state or province to
province. Second, both countries had federal privacy laws that regulated
the conduct of government actors, but not that of private actors. Today,
both countries still offer a highly variable set of privacy protections
124. Gordon Atherley, Sneaking a Peak, 34 THE MEDICAL POST (Feb. 24, 1998),
available at http:llwww.medicalpost.comlmdlinklenglishlmembers/medpostldata/3408/09.
hitm.
125. Industry Canada is a federal department designed to foster a competitive Canadian
economy. Industry Canada is involved in a multitude of activities such as setting
telecommunications policy and promoting investment and trade. See Industry Canada,
About Industry Canada, at http://www.ic.gc.calcmbWelcomeic.nsf/ICPages/
AboutIndustryCanada (last visited Jan. 30, 2001).
126. INDusTRY CANADA, PRIvAcY: THE PROTECTION OF PERSONAL INFORMATION (1998),
available at http://www.e-com.ic.gc.calenglish/privacy/632d2.html (last visited Jan. 27,
2001).
127. Id. pt. 3.
128. The Commissioner noted that these recommendations are fundamental principles of
the European Union's Directive on Data Protection and should be reflected in Canadian law.
David H. Flaherty, Submission to Industry Canada Re: The Information Highway (Dec. 22,
1994), available at http://www.oipcbc.orglpublications/other/Industry-Canada.html.
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depending on a person's physical geographical location within each
country. Canada, however, has repaired its public/private dichotomy with
the passage of the PIPED Act. With respect to personally identifiable
health information, the United States has also adopted a comprehensive
federal law aimed at private actors. Until the PIPED Act and the Privacy
Rule came into being, the Canadian and American legal privacy
frameworks were substantially similar in the privacy protections that they
afforded to individuals.
b. Differences
One of the most striking differences between Canada and the United
States in terms of national structure resides in their respective health care
systems. While the United States has a privatized system requiring citizens
to pay for their own health care programs and services (privately financed
and privately delivered), Canada offers a predominantly publicly financed,
privately delivered health care system. The Canadian system, known as
"Medicare," "provides access to universal, comprehensive coverage for
medically necessary hospital, in-patient and out-patient physician
services.'29 This difference in health care structure results in differing
regulation of health care providers with respect to personally identifiable
patient data.
Furthermore, the United States and Canada differ in their approaches
to privacy in general, and specifically with regard to informational health
privacy. As an initial matter, since 1977 Canada has had a politically
appointed position of federal Privacy Commissioner that is accountable to
Parliament" The Canadian Privacy Commissioner surely gives a citizen a
certain level of comfort that reported invasions of privacy would be
investigated and, where necessary, prosecuted. By contrast, the American
system offers no such direct point of contact for information privacy
violations against a citizen. The FTC has broad authority to investigate and
prosecute unfair and deceptive trade practices when a Web site has violated
its own posted privacy policy; however, this does not grant the citizenry
any special protections or private rights of action.
Moreover, Canada's recent enactment of the PIPED Act provides a
broad-based privacy protection initiative. Aside from laws geared at
industry-specific private actors (e.g., video rental industry, cable TV
129. HEALTH SYSTEM AND POLICY DIVISION OF HEALTH CANADA, CANADA'S HEALTH
CARE SYSTEM 1 (1999), at http://www.hc-sc.gc.ca/datapcb/datahesa/hlthsys/Ehlthsys.pdf
(last visited Feb. 1, 2001).
130. Privacy Comm'r of Canada, Our Mission and Our Mandate, at
http://www.privcom.gc.caenglish/02_01__e.htm (last visited Feb. 1, 2001).
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industry), the United States does not have a comprehensive or umbrella
privacy law in place. Such industry-specific laws include the Video Privacy
Protection Act, which attempted to curb privacy disclosures and privacy
invasions of consumers renting videos, and the Cable Communications
Policy Act3 with similar privacy provisions.
While HHS's Privacy Rule under HIPAA constitutes a landmark step
in protecting the confidentiality of personal medical information, it
continues a legacy of industry-specific, patchwork privacy protection,
instead of a broad-based privacy protection mechanism. In addition, as
discussed earlier, the Privacy Rule in its present definition of "covered
entities' ' 3 may not directly implicate health-related Web sites. It may
reach these Web sites, however, through the restrictions laid out for defined
"business associates," or through the offered definition of health care
providers. Finally, the Privacy Rule does not offer a private right of action.
Thus, the American consumer is somewhat left without remedy from
individual invasions of privacy. By contrast, the Canadian efforts seem to
support a more genuine overarching privacy protection goal for its
citizenry, rather than the patchwork, sector-by-sector focus of the United
States's privacy protection framework.
c. Reasoning for Similarities and Differences
To address alleged privacy violations, Canada maintains a national
Privacy Commissioner, as do some provinces. Thus, in relation to the
United States, Canada is much more advanced on the implementation side
of privacy policy because of the existence of these official positions, which
are designed to balance greater openness and accountability for general
information against the protection of personal information of the citizenry.
When Americans encounter privacy obstacles or invasions, they usually
131have to sue in courts to achieve common-law redress, whereas in Canada,
affected citizens may first obtain the backing and prosecutorial support of
131. 18 U.S.C. § 2710 (1994).
132. 47 U.S.C. § 551 (1994).
133. HIPAA limits application of the Privacy Rule to the following "covered entities:" (1)
health plans, (2) health care clearinghouses, and (3) health care providers who transmit
health information in electronic form in connection with transactions referred to in section
1173(a)(1)of the Act. Health Insurance Portability and Accountability Act of 1996 § 1172,
42 U.S.C. § 1320d-1 (Supp. IV 1998).
134. See Privacy Comm'r of Canada, Information and Privacy Organizations in Canada,
at http://www.privcom.gc.ca/english/02_03_01_e.htm (last visited Feb. 1, 2001).
135. There are four so-called common-law "privacy torts." These include intrusion on
seclusion or solitude, public disclosure of private facts, publicity in a false light, and
appropriation of name or likeness. William L. Prosser, Privacy, 48 CAL. L. REv. 383, 388-
89 (1960).
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the Privacy Commissioner.136
From a policy standpoint, the Canadian government may value
privacy more than it values capitalism and freedom of enterprise, or simply
view privacy as an economy-building tool. By contrast, the United States
values private-sector sovereignty and the societal benefits of
entrepreneurial spirit. In addition, in the United States, privacy may be
characterized as harmful to economic interests. This difference in value
structure may explain the differences in privacy strategies between the two
countries. Moreover, the resulting value structure will depend in part on the
power struggle between private industry and consumer protection
advocates.1 37 Notwithstanding, the highly sensitive nature of patient
information resulted in the United States enacting a comprehensive health
privacy law.
Finally, a critical reason for the differences in privacy protections for
personal medical data stems from the differences in the health care systems
themselves. Both the United States and Canada have enacted
comprehensive federal privacy legislation aimed at governmental actors.
Because many of Canada's governmental services include forms of health
care delivery, personally identifiable medical data was naturally included
in the mix of privacy protections. By contrast, the federal privacy law
covering actions of government actors did not affect the privatized U.S.
health care system. Thus, the system of health care delivery in each country
has led to a profound difference in privacy protections afforded to medical
data.
B. Internet Pharmacy Sales
The United States and Canada primarily regulate the sale of
prescription drugs at the federal level. ' In addition, pharmacies in both
Canada and the United States must seek local licenses from each
state/province/territory in which they wish to sell prescription medications.
136. The Privacy Act gives the Privacy Commissioner broad powers to investigate
individuals' complaints, to launch his own complaint, and to audit federal agencies'
compliance with the Act. See Privacy Act, R.S.C., ch. P-21, §§ 29, 37(1) (1985) (Can.).
137. An increasing number of corporations favor a federal privacy law over fifty varying
state rules. In addition, allowing states to legislate privacy standards could produce
obstacles for consumers seeking the benefit of choice of law and forum language included
in privacy policies. See Declan McCullagh, Should States Regulate Privacy? WIRED NEws
(Feb. 1, 2001), at http://www.wired.com/news/politics/0,1283,4151 1,00.html.
138. See 21 U.S.C. § 331 (Supp. IV 1998); Controlled Drugs and Substances Act, S.C.,
ch. 19 (1996) (Can.), Controlled Drugs and Substances Act, S.C., ch. 19 (1996) (Can.).
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1. United States
Licensure to conduct pharmaceutical sales is not currently regulated
at the federal level. Instead, licensure is required for each state in which a
pharmaceutical company wants to conduct sales.
a. Professional Licensure
All fifty states have laws that regulate the relationship between the
patient/consumer and health care professional. For purposes of this
Comment, the relevant laws are those that set requirements for licensure of
health care professions and penalties for practicing without a license,
pharmacy licensure, and accreditation requirements. Additionally, some
health care professions may have professional codes of ethics, some of
which are enforceable by licensure or ethics boards. For example, the
American Medical Association ("AMA") has warned doctors about the
need to first "examine" a patient before providing an online prescription.1
39
Every state in the nation requires physicians, psychiatrists, and
registered nurses to be licensed by the state in which they practice their
profession. Variations exist in the licensure requirements of each state,
which can have significant implications for a health-related Web site.
Consequently, there is a growing concern over the current licensure system
because of Internet and telehealth 14 applications, where state borders are
evaporating.
With an eye toward embracing the new electronic age, many options
have been proposed for developing a new interstate licensure framework.
While these proposals currently apply to health care professionals, they
could also apply to organizations selling prescription drugs, such as those
engaged in Internet pharmacy sales. For example, the College of American
Pathologists proposed a system whereby state boards grant licenses to
health professionals in other states that have equivalent standards.14 An
alternative solution is the National Council of State Boards of Nursing
program, which is based on a system of general mutual recognition,1 42 a
139. See Gary Baldwin, AMA Warns Doctors on Dangers of Web Pill Pushing, AM.
MED. NEws, July 19, 1999, at 23.
140. Telehealth is defined as the "use of electronic information and telecommunications
technologies to support long-distance clinical health care, patient and professional health-
related education, public health and health administration." Office for the Advancement of
Telehealth, Welcome, at http:lltelehealth.hrsa.gov/welcome.htm (last visited Feb. 1, 2001).
141. See Joanne Kumekawa, Telehealth Update, Issue: Licensure Update, available at
http://telehealth.hrsa.gov/pubs/licens.htm (last visited Feb. 1, 2001).
142. In November 1998, the National Council adopted an Interstate Nurse Licensure
Compact. This Compact created a unified standard for nurses' licenses and gave nurses the
ability to practice telemedicine in any state that adopts the Compact. At this time, nine states
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concept "in which the licensing authorities voluntarily enter into an
agreement to legally accept the policies and processes (licensure) of a
licensee's home state.' ' 43 Under mutual recognition, the licensee secures a
license in the licensee's home state and need not obtain additional licenses
to practice in other states that have also adopted the program.' 44 Thus,
several solutions can be imagined that both secure state oversight and high
standards of licensure and embrace interstate health care delivery.
b. Sale of Prescription Drugs Over the Internet
A recent event highlights the problem of prescription drugs sold over
the Internet. In August 2000, a Miami, Florida-based pharmaceutical
supply company was charged with conspiring to illegally sell prescription
drugs over the Internet.' 45 Purportedly, the Web site provided both online
and telephone consultations "with real doctors;" however, consumers did
146not actually receive medical consultations before getting prescriptions.
Instead, government officials alleged that an Alabama doctor repeatedly
wrote phony prescriptions without any contact with the consumers, and an
Alabama pharmacy filled the prescriptions. 47 Officials from the Food and
Drug Administration ("FDA") and DOJ said the defendants were indicted
for conspiring to sell such drugs as Viagra, Propecia, and Claritin-D to
consumers who did not have valid prescriptions.1
41
Although many reputable Internet pharmacies exist today, the FDA is
concerned with the public health implications of rogue Web site operators,
owners, and affiliates. "49 Such concerns include the sale of prescription
drugs without a prescription, the sale of unapproved new drugs, health
fraud, and counterfeit medications. ' While working with state and federal
agencies to better coordinate enforcement efforts of illegal online sales and
to analyze ways to regulate online sales, the FDA nonetheless maintains
that a self-regulatory framework is crucial to the success of online
pharmacies.'5 1 In testimony before the House Commerce Committee, the
have adopted the Compact. See, e.g., UNITED STATES DEP'T OF COMMERCE, TELEMEDICINE
REPORT TO CONGRESS 27-50 (1997).
143. Id. at 37.
144. Id. at 37-38.





149. See Hearings, supra note 2, at 93-102 (testimony of Janet Woodcock).
150. Id.
151. Id at 95:
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FDA took the position that "government should encourage private sector
leadership in achieving a safe marketplace.'
52
Working under this self-regulatory framework, the U.S. National
Association of Boards of Pharmacy ("NABP")' 53 has implemented a
voluntary certification program in which participating Internet pharmacies
must meet state licensing criteria and Verified Internet Pharmacy Practice
Site ("VIPPS")-4 criteria. Pharmacies must apply, pay an annual licensing
fee, and undergo a site inspection. 55 The VIPPS certification under the
NABP requires: compliance with state licensing and inspection in the home
state and each state where pharmaceuticals are dispensed; adherence to the
patient's right to privacy, authentication, and security; implementation of a
recognized quality assurance program; and meaningful consultation
between patients and pharmacists. 56 Under this regime, the state pharmacy
boards act as one regulatory body. '57 Additionally, former President Clinton
announced a plan to require online pharmacies to receive FDA certification
before they sell prescription drugs over the Internet.
58
Furthermore, the AMA has its own set of self-regulatory guidelines
governing its Web sites.' 59 The goal of AMA's code of ethics is to reduce
worries about misleading information and breaches of confidentiality in the
online world. The AMA stresses disclosure, informed consent, privacy, and
confidentiality, and it places a restriction on inserting advertisements next
to online articles on the same topic.160 These guidelines apply to health
information sites, journal articles, and other sources of consumer medical
information. Nonetheless, these guidelines do not address online diagnosis
and prescription fulfillment without direct patient contact.1Aside from self-regulatory measures, the Federal Food, Drug, and
152. Id
153. The NABP is a professional organization representing state boards of pharmacy in
all fifty states. NABP assists state licensing boards in developing, implementing, and
enforcing uniform standards to protect the public health. See NABP, Who We Are, at
http://www.nabp.net/ (last visited Feb. 1, 2001).
154. VIPPS was developed by NABP in the spring of 1999 as a response to public
concern of the safety of pharmacy practices on the Internet. See NABP, VIPPS, at http://
www.nabp.net/vipps/intro.asp (last visited Feb. 1, 2001) [hereinafter VIPPS].
155. See VIPPS, VIPPS Certification Process, at http://www.nabp.netlvippslpharmacyl
inlro.asp (last visited Feb. 1, 2001).
156. VIPPS, supra note 154.
157. Id.
158. Online Pharmacies: Clinton Proposes Greater FDA Authority over Online
Phannacies; Reactions Skeptical, 9 Health Law Rep. (BNA) 12 (Jan. 6, 2000).
159. AMA, Principles Governing AMA Web Sites, at http://www.ama-assn.org/
ama/pub/category/1905.html (last visited Feb. 1, 2001).
160. Id.
161. Id.
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Cosmetic ("FDC") Act is currently the primary enforcement mechanism by
which the DOJ may protect consumers engaging in the purchase of
prescription drugs over the Internet. In establishing the system that
currently regulates the sale of prescription drugs, Congress developed a
plan that relied on both the physician and the pharmacist to protect patients
163from knowing or accidental misuses of medicines. Under the FDC Act,
drugs that are considered prescription drugs may be distributed only with a
valid prescription under the professional supervision of a physician.64 In
addition, the FDC Act prohibits the manufacture of misbranded or
adulterated drugs. A prescription drug is considered "misbranded" if it is
not dispensed pursuant to a valid prescription in accordance with 21 U.S.C.
§ 353(b). 166 The FDC Act is also violated when misbranded drugs are
distributed or introduced into interstate commerce.167
Other enforcement mechanisms for the sale of prescription drugs over
the Internet include the Controlled Substances Act, 16 the FTC Act,169 and
170federal mall and wire fraud statutes. The Controlled Substances Act
prohibits dispensing controlled substances without a valid prescription.
71
As previously mentioned, the FTC Act protects consumers from unfair or
deceptive acts or practices. To the extent that an online pharmacy makes
false representations about health-related services on its Web site, the FTC
Act could be used in a civil enforcement action to eliminate such an unfair
or deceptive trade practice. Finally, depending on the facts of a particular
case, federal mall and wire fraud statutes could be invoked in either a
criminal or civil proceeding anytime an online pharmacy defrauds a
consumer using the postal or telecommunications systems.
2. Canada
In Canada, the federal government approves pharmaceutical products,
but the individual provinces and territories administer the health care plans,
including any pharmacy programs.172 Currently, it is illegal for Canadian
162. Hearings, supra note 2, at 87 (testimony of Ivan Fong).
163. See 21 U.S.C. § 353(b)(1) (Supp. IV 1998).
164. Id.
165. Id. § 331(a) (1994).
166. Id. § 353(b)(4)(A) (Supp. IV 1998).
167. Id. § 331(a) (1994).
168. See id. §§ 822, 829, 841.
169. See 15 U.S.C. § 45.
170. See 18 U.S.C. § 1345 (Supp. IV 1998).
171. See 21 U.S.C. § 829(a) (1994).
172. See Nat'l Ass'n of Pharmacy Regulatory Auths., Canada's Pharmacy Regulatory
Authorities, at http://www.napra.org/protect/provincial.html (last visited Feb. 1, 2001)
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pharmacies to provide prescriptions over the Internet. 73 It is lawful,
however, to link an Internet pharmacy with a bricks-and-mortar pharmacy,
which locally dispenses the medication. 74 Any licensed pharmacy
providing Internet services must meet the standards of practice within its• 175
province. 7 Canada's federal enforcement mechanisms for illegal online
sales include the Controlled Substances Ac 176 and the Food and Drugs
Act.
177
Self-regulatory measures are also prominent in Canada. In 1998, the
National Association of Pharmacy Regulatory Authorities ("NAPRA") 'T
developed the Model Standard of Practice for Canadian Pharmacists,
which provides guiding principles for the electronic transmission of
prescriptions.179 NAPRA asked Health Canada to interpret federal
legislation to allow for online transmission.8 In September 1999, NAPRA
initiated discussions with the United States NABP to possibly adopt or
adapt the VIPPS program for use in Canada. 18' Currently, Canada is
making progress toward adopting this or a similar certification program.
182
IV. CONCLUSION
In the final analysis, the United States and Canadian approaches to
protecting an individual's right to privacy and regulating Internet
pharmacies do not differ so greatly. The most noticeable difference arises
in a general right to privacy in terms of protecting personally identifiable
information.
While Canada has recently taken a strong position in doing away with
the hodgepodge of privacy laws that govern only specific industries or that
simply regulate public actors, the United States is looking primarily toward
self-regulatory mechanisms to protect against private-actor invasions of
privacy. In addition, the United States maintains a sectoral approach to
privacy protections. In one sense, a sectoral approach may provide greater
(citing Canada's individual pharmacy regulatory authorities).
173. Canadian Pharmacists Ass'n, supra note 22.
174. Id.
175. Id.
176. Controlled Drugs and Substances Act, S.C., ch. 19 (1996) (Can.).
177. Food and Drugs Act, 1.S.C., ch. F-27 (1985) (Can.).
178. NAPRA, Formation and Purpose, at http://www.napra.org/about/purpose.html (last
visited Feb. 1, 2001). NAPRA is a public-sector association that facilitates the activities of
provincial pharmacy regulatory authorities. Id.
179. NAPRA, Model Standards of Practice for Canadian Pharmacists (Apr. 1998), at
http://www.napra.org/practice/standards.html (last visited Feb. 1, 2001).
180. Canadian Pharmacists Ass'n, supra note 22.
181. Id.
182. Id.
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privacy protection because of the specificity inherent in legislation geared
at a single subject area, and this may be especially beneficial in terms of
the highly sensitive nature of personal medical data. Nonetheless, because
of the Internet's vulnerabilities and the unknown future for online tracking
and profiling, perhaps a baseline framework of privacy standards for all
personally identifiable information should be enacted into federal law
before consumers lose confidence in the online medium or states enact
widely divergent legislation. Restoring public trust in our health care
system and providing very specific limits on individually identifiable
health information was possibly the reasoning for enacting HIPAA and its
Privacy Rule.
Pharmacy sales are highly regulated transactions in both the United
States and Canada. Both countries have enacted federal laws that overlay
state-, province-, and territory-specific licensure laws. Additionally, both
countries face difficult decisions as to how to facilitate and encourage
growth in this valuable medium, while at the same time guarding against
fraudulent activity. Furthermore, states, provinces, and territories are fond
of local licensure and may lodge significant objections to any national
solution that infringes upon their sovereignty. Nonetheless, before the
Internet pharmacy can realize its full potential and have continuity in
operations, there should be a national or mutual recognition approach to
local licensure. If implemented thoroughly and with proper oversight, such
a program would both energize this valuable medium of pharmaceutical
sales and protect consumers in the online world through continued patient-
physician contact and examinations.
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